treatments for mds and secondary aml - part 2, high-risk
Published 3 months ago • 113 plays • Length 6:13Download video MP4
Download video MP3
Similar videos
-
15:30
treatments for mds and secondary aml, with drs o. odenike and d. sallman
-
8:11
non transplant treatments for mds & secondary aml (co-chair summary)
-
4:26
treatments for mds and secondary aml part 1, low-risk mds
-
1:13:29
understanding higher risk mds and transtion to aml
-
1:29:30
myelodysplastic syndromes and secondary aml– update on diagnosis and treatment
-
27:20
myelodysplastic syndromes and secondary aml: an update on diagnosis and treatment
-
1:00:54
managing higher risk mdl and aml
-
34:15
from mds to aml: what every patient needs to know 11/28/17
-
2:13
optimizing therapy for patients with high-risk mds
-
27:38
treatment decision-making through the spectrum of mds
-
1:01:45
new and emerging therapies for mds
-
6:50
the role of bmt in treatment-related mds and aml
-
7:01
immune based therapies for mds and aml
-
1:08
approved and emerging treatment options for transplant-ineligible patients with high-risk mds
-
6:33
myelodysplastic syndromes - causes, symptoms, diagnosis, treatment, pathology
-
4:11
comparing treatment options for treated secondary aml
-
1:24
can early treatment for mds prevent progression to aml? #aml
-
1:36
innovations in mds and aml treatment
-
5:36
david sallman: magrolimab plus azacitidine effective in mds and aml